Adding Deep Front Line Myofascial Release to Selected Exercises in Patients With Knee Osteoarthritis

February 5, 2024 updated by: Hoda mohamed Ahmed, Cairo University

Effects of Adding Deep Front Line Myofascial Release to Selected Exercises in Patients With Knee Osteoarthritis

the aim of the study is to investigate the effect of deep front line myofascial release to selected exercises in patients with knee osteoarthritis

Study Overview

Status

Completed

Conditions

Detailed Description

: Knee osteoarthritis (KOA) also known as degenerative joint disease, is typically the result of wear and tear and progressive loss of articular cartilage.

The myofascial meridian is a new approach to the facial restriction .the knee capsules, the adductor muscles and the tipialis posterior are part of the deep front line which is a line of the myofascial meridian.

Exercise is the highest evidence in the treatment of knee osteoarthritis. The myofascial release is effective in the treatment of knee osteoarthritis so the study will investigate the effect of adding deep front line myofascial release to selected exercises in patients with knee osteoarthritis.

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Giza, Egypt
        • Hoda Mohamed Ahmed

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Mild to moderate unilateral or bilateral medial tibiofemoral OA grade II-III (K/L).
  • The age of the participants will range from 45 to 60 years old .
  • BMI ranged from 20-30 kg/m2

Exclusion Criteria:

  1. Severe knee OA (grade IV according to K/L classification).
  2. Congenital or acquired inflammatory, rheumatic or neurological (systemic or local) diseases involving the knee.
  3. Patients receiving oral or injected corticosteroids for the last 3 months .
  4. History of knee surgery/fracture.
  5. Patients with ACL and meniscus injury

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: control group
The control group received selective exercises therapy in the form of strengthening and stretching exercises for selective muscles of hip and knee
strengthening of the gluteus maximus and medius, calf muscles stretching for calf and hamstring muscles
Experimental: study group
The study group received selective exercises therapy in the form of strengthening and stretching exercises for selective muscles of hip and knee, plus myofascial release technique of the deep front line.
strengthening of the gluteus maximus and medius, calf muscles stretching for calf and hamstring muscles
myofascial release using instrument assisted soft tissue mobilization

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
rang of motion
Time Frame: up to four weeks
using digital inclinometer
up to four weeks
joint position sense
Time Frame: up to four weeks
using digital inclinometer for target angle 30 degree knee flexion
up to four weeks
pain intensity
Time Frame: up to four weeks
The scale that will be used the visual analogue scale;each subject will instructed to record pain intensity on line of 100mm. Starting from no pain on the leftto the most sever pain imaginable on the right Patient will choose the point which describe his pain.the more the score toward the end the more severe pain
up to four weeks
function
Time Frame: up to four weeks

The Arabic version of reduced Western Ontario and McMasters University Osteoarthritis Index (ArWOMAC) index will be used to measure functional disability.is a self-administered questionnaire consisting of 24 items divided into 3 subscales:

  • Pain (5 items): During walking, using stairs, in bed, sitting or lying, and standing upright
  • Stiffness (2 items): After first waking and later in the day Physical Function (17 items).The scores for each subscale are summed up, with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function.Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations
up to four weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: hoda m Ahmed, bachelor, phyical therapist at Cairo university hospitals

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2023

Primary Completion (Actual)

April 1, 2023

Study Completion (Actual)

May 15, 2023

Study Registration Dates

First Submitted

April 1, 2023

First Submitted That Met QC Criteria

April 1, 2023

First Posted (Actual)

April 14, 2023

Study Record Updates

Last Update Posted (Actual)

February 7, 2024

Last Update Submitted That Met QC Criteria

February 5, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on exercises

Subscribe